{"version":"1.0","provider_name":"Neuraxpharm","provider_url":"https:\/\/www.neuraxpharm.com\/uk","author_name":"Jaime Fern\u00e1ndez","author_url":"https:\/\/www.neuraxpharm.com\/uk\/blog\/author\/jaime","title":"LLU\u00cdS P\u00c9REZ","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XwVKpEFoNu\"><a href=\"https:\/\/www.neuraxpharm.com\/uk\/about-us\/executive-committee\/lluis-perez\">LLU\u00cdS P\u00c9REZ<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.neuraxpharm.com\/uk\/about-us\/executive-committee\/lluis-perez\/embed#?secret=XwVKpEFoNu\" width=\"600\" height=\"338\" title=\"&#8220;LLU\u00cdS P\u00c9REZ&#8221; &#8212; Neuraxpharm\" data-secret=\"XwVKpEFoNu\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.neuraxpharm.com\/uk\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business https:\/\/www.linkedin.com\/in\/lluis-perez-796bb934\/ Neuraxpharm LLU\u00cdS P\u00c9REZ Llu\u00eds joined Neuraxpharm as Chief Financial Officer (CFO) in April 2018. His professional background and expertise are focused on the fields of finance and corporate finance control, including extensive international experience within large [&hellip;]","thumbnail_url":"https:\/\/www.neuraxpharm.com\/uk\/wp-content\/uploads\/sites\/19\/2023\/03\/lluis-perez.jpg"}